LabCompass

Pedro C. Silberman

Medicine · The Ohio State University

OpenAlex ORCID
Mid career · publishing since 2014
Glioma Diagnosis and TreatmentChromatin Remodeling and CancerCAR-T cell therapy researchNanowire Synthesis and ApplicationsMicroRNA in disease regulation

Publications

14

Citations

1,349

Est. group size

~1

Recurring co-author estimate

Active years

13

Publishing since 2014

Research summary
AI-generated

Pedro C. Silberman's research focuses on brain tumors called gliomas, particularly how loss of a gene called ATRX changes the way tumor cells' DNA is packaged (chromatin) and how this drives aggressive tumor behavior. More recently, his work has expanded into engineering cells—including CAR-T immune cells—to deliver drugs directly to tumors or the brain in a targeted way, aiming to improve treatment effectiveness while reducing side effects.

Glioma biology and epigeneticsATRX gene function in cancerEngineered cell-based drug deliveryCAR-T cell therapy for solid tumorsChromatin remodeling in disease

Publication output has been sporadic over the past decade with several gap years, but shows a recent uptick with a notable increase in 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.4/year recently
2017: 1 publication172018: 2 publications18192020: 1 publication20212022: 1 publication22232024: 1 publication242025: 4 publications4252026: 1 publication26
Recent publications
Publishes in
  • Nature Communications×2
  • Journal of Clinical Oncology×2
  • Neuro-Oncology×2
  • Science Advances×1
  • Cancers×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile